Certified by Founder Lodge
Longevity Vision Fund
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $300,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer, healthier lives. The
| Company | Date | Round | Raised |
|---|---|---|---|
 Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
